Patents by Inventor Asaf A. Qureshi
Asaf A. Qureshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6733799Abstract: A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting of an enzyme treated stabilized rice bran, an insolubilized fraction and mixtures thereof, thereby reducing serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels in said mammal.Type: GrantFiled: May 5, 2003Date of Patent: May 11, 2004Assignee: The RiceX CompanyInventors: Rukmini Cheruvanky, Patricia McPeak, Reddy Sastry V. Cherukuri, Ike Lynch, Asaf A. Qureshi
-
Publication number: 20030203058Abstract: A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting of an enzyme treated stabilized rice bran, an insolubilized fraction and mixtures thereof, thereby reducing serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels in said mammal.Type: ApplicationFiled: May 5, 2003Publication date: October 30, 2003Applicant: The RiceX CompanyInventors: Rukmini Cheruvanky, Patricia McPeak, Reddy Sastry V. Cherukuri, Ike Lynch, Asaf A. Qureshi
-
Patent number: 6558714Abstract: A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting of an enzyme treated stabilized rice bran, an insolubilized fraction and mixtures thereof, thereby reducing serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels in said mammal.Type: GrantFiled: November 16, 2001Date of Patent: May 6, 2003Assignee: The RiceX CompanyInventors: Rukmini Cheruvanky, Patricia McPeak, Reddy Sastry V. Cherukuri, Ike Lynch, Asaf A. Qureshi
-
Publication number: 20020086069Abstract: A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting of an enzyme treated stabilized rice bran, an insolubilized fraction and mixtures thereof, thereby reducing serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels in said mammal.Type: ApplicationFiled: November 16, 2001Publication date: July 4, 2002Inventors: Patricia McPeak, Rukmini Cheruvanky, Reddy Sastry V. Cherukuri, Ike Lynch, Asaf A. Qureshi
-
Patent number: 6350473Abstract: A method for reducing mammalian serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels, by ingesting a stabilized rice bran derivative selected from the group consisting of an enzyme treated stabilized rice bran, an insolubilized fraction and mixtures thereof, thereby reducing serum total cholesterol, LDL cholesterol, apolipoprotein B and triglyceride levels in said mammal.Type: GrantFiled: July 24, 2000Date of Patent: February 26, 2002Assignee: The Rice CompanyInventors: Rukmini Cheruvanky, Patricia McPeak, Reddy Sastry V. Cherukuri, Ike Lynch, Asaf A. Qureshi
-
Patent number: 6239171Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiathermogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: October 28, 1998Date of Patent: May 29, 2001Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 6204290Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: October 28, 1998Date of Patent: March 20, 2001Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 6143770Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: October 28, 1998Date of Patent: November 7, 2000Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 5919818Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: December 16, 1997Date of Patent: July 6, 1999Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 5908940Abstract: The present invention relates to processes for obtaining Tocol products, such as tocotrienols, tocopherols and tocotrienol-like compounds from plant sources in high yields. More particularly, this invention relates to processes for stabilizing and recovering Tocol products from plant materials, such as cereals, grains and grain oils. The Tocol products recovered according to this invention are useful in pharmaceutical compositions, food formulations and dietary supplements. These compositions, formulations and supplements advantageously lower the blood level of low density lipoproteins and total serum cholesterol in humans and animals.Type: GrantFiled: January 5, 1996Date of Patent: June 1, 1999Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Kenneth W. Becker, Asaf A. Qureshi, D. Michael Wells
-
Patent number: 5821264Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: September 24, 1996Date of Patent: October 13, 1998Assignee: LipoGenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 5591772Abstract: The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical compositions, foodstuffs and dietary supplements. This invention also relates to the use of tocotrienols, tocotrienol-like compounds, and mixtures thereof, as hypocholesterolemic, antithrombotic, antioxidizing, antiatherogenic, antiinflammatory and immunoregulatory agents, or as agents useful to decrease lipoprotein (a) concentration in the blood or to increase feed conversion efficiency.Type: GrantFiled: August 15, 1994Date of Patent: January 7, 1997Assignee: Lipogenics, Inc.Inventors: Ronald H. Lane, Asaf A. Qureshi, Winston A. Salser
-
Patent number: 5348974Abstract: This invention relates to the use of tocotrienol, gamma-tocotrienol and delta-tocotrienol in reducing hypercholesterolemia, hyperlipidemia and thromboembolic disorders in mammals. The isolation of these tocotrienols from natural sources and their chemical synthesis is disclosed. The present invention also relates to prodrugs and pharmaceutical compositions of gamma-tocotrienol, delta-tocotrienol and tocotrienol and uses thereof.Type: GrantFiled: February 10, 1993Date of Patent: September 20, 1994Assignee: Bristol-Myers Squibb CompanyInventors: John J. Wright, Bradley C. Pearce, Rex Parker, Asaf A. Qureshi
-
Patent number: 5217992Abstract: This invention relates to the use of tocotrienol, gamma-tocotrienol and delta-tocotrienol in reducing hypercholesterolemia, hyperlipidemia and thromboembolic disorders in mammals. [The isolation of these tocotrienols from natural sources and their chemical synthesis is disclosed.] The chemical synthesis of these tocotrienols is disclosed. The present invention also relates to prodrugs and pharmaceutical compositions of gamma-tocotrienol, delta-tocotrienol and tocotrienol and uses thereof.Type: GrantFiled: September 17, 1990Date of Patent: June 8, 1993Assignee: Bristol-Myers Squibb CompanyInventors: John J. Wright, Bradley C. Pearce, Rex Parker, Asaf A. Qureshi
-
Patent number: 4603142Abstract: A method of lowering cholesterol comprises administering to an animal safe and effective amounts of d-.alpha.-tocotrienol. A method of extracting d-.alpha.-tocotrienol from natural sources and pharmaceutical compositions containing d-.alpha.-tocotrienol are also disclosed.Type: GrantFiled: June 1, 1984Date of Patent: July 29, 1986Assignee: Wisconsin Alumni Research FoundationInventors: Warren C. Burger, Asaf A. Qureshi, Charles E. Elson